Addus HomeCare shareholders approve 2026 meeting items
Addus HomeCare Corporation reported the results of its 2026 annual stockholder meeting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Addus HomeCare Corporation reported the results of its 2026 annual stockholder meeting. Stockholders representing 17,557,334 shares of common stock, out of 18,664,776 shares outstanding and entitled to vote, were present in person or by proxy. They elected Michael Earley and Veronica Hill-Milbourne as Class II directors with terms expiring at the 2029 annual meeting, ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and approved on an advisory, non-binding basis the compensation of the company’s named executive officers as described in the proxy statement.
8-K Event Classification
Key Figures
Key Terms
broker non-votes financial
independent registered public accounting firm financial
advisory, non-binding basis financial
named executive officers financial
Class II directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Addus HomeCare (ADUS) stockholders approve at the 2026 annual meeting?
Who was elected to the Addus HomeCare (ADUS) board as Class II directors in 2026?
What were the vote totals for Addus HomeCare (ADUS) auditor ratification for 2026?
How did Addus HomeCare (ADUS) stockholders vote on executive compensation in 2026?
When do the newly elected Addus HomeCare (ADUS) Class II director terms expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.